C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61P 37/00 (2006.01) A61P 43/00 (2006.01) C07K 16/24 (2006.01) C07K 16/46 (2006.01) C12P 21/08 (2006.01)
Patent
CA 2396212
An IL-1.beta. binding molecule, in particular an antibody to human IL-1.beta., especially a human antibody to human IL-1.beta. is provided, wherein the CDRs of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritides.
L'invention concerne une molécule de liaison d'interleukine 1.beta., notamment un anticorps anti-interleukine 1.beta. humain, plus spécifiquement un anticorps humain anti-interleukine 1.beta., les régions hypervariables des chaînes légères et lourdes renfermant des séquences d'acides aminés comme défini. Cette molécule est utilisée dans le traitement d'une maladie ou d'un trouble à médiation par interleukine-1, par exemple, l'ostéo-arthrite, l'ostéoporose et autres types d'arthrite inflammatoire.
Di Padova Franco E.
Gram Hermann
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Recombinant antibodies to human interkleukin-1 beta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant antibodies to human interkleukin-1 beta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant antibodies to human interkleukin-1 beta will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2015294